CTSO CytoSorbents Corporation
CytoSorbents Corporation (CTSO) is expected to report earnings on February 11, 2027, after the market close. The consensus earnings estimate is a loss of $0.70 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -21.9% since its last earnings release on November 12, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About CytoSorbents Corporation
Cytosorbents Corp is a development stage company. The Company, through its subsidiary, is engaged in the research, development and commercialization of medical devices.
Sector
Healthcare
Industry
Medical Instruments/Supply
Charts powered in part by Lightweight Charts™ by TradingView.